PE  HealthpointCapital

http://www.healthpointcapital.com





     Office Locations:

505 Park Avenue, 12th Floor
New York, NY 10022
Phone: 212-935-7780
Fax: 212-935-6878

 

Stages:

  • Middle Market


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    HealthpointCapital is a values-driven, research-based private equity firm exclusively focused on the orthopedic and dental device businesses. HealthpointCapital manages $750 million in institutional capital, having closed in 2007 HealthpointCapital Partners II, LP, at $420 million. As of June 2007, HealthpointCapital had completed 12 investments, creating five platform companies in the orthopedic and dental industries since 2004. All investments had been made pursuant to the firm's focus on making proprietary investments which capitalize on the most compelling trends in the musculoskeletal industry, in which the firm is able to purchase a controlling or significant equity stake in growth businesses. To date, over $325 million in equity capital has been invested. The firm has completed the successful initial public offering of Alphatec Spine and the full sale of Nexa Orthopedics. On a combined basis, all portfolio companies have increased revenues more than 2.5 times from the initial time of investment, with an average holding period of just 1.5 years.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    John C. McCormick Senior Director
    John H. Foster Chairman and Managing Director
    Laing F. Rikkers Managing Director
    Mortimer Berkowitz President & Managing Director

     

    Portfolio companies include:


      Alphatec Spine
        web link


      BioHorizons
        web link


      Blue Belt Technologies
        web link


      Dental Technologies
        web link


      Nexa
        web link


      OrthoAccel
        web link


      Scient'x
        web link


     

    Recent News: